연구동향 분석

Expression of Sarcosine Metabolism-Related Proteins in Invasive Lobular Carcinoma: Comparison to Invasive Ductal Carcinoma

차윤진 구자승 정우희 조남훈 2015년

논문상세정보
인용/피인용
' Expression of Sarcosine Metabolism-Related Proteins in Invasive Lobular Carcinoma: Comparison to Invasive Ductal Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • breast cancer
  • lobularcancer
  • sarcosine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,138 0

0.0%

' Expression of Sarcosine Metabolism-Related Proteins in Invasive Lobular Carcinoma: Comparison to Invasive Ductal Carcinoma' 의 참고문헌

  • Trends in incidence rates of invasive lobular and ductal breast carcinoma
    Li CI JAMA 289 : 1421 ~ 1424 [2003]
  • Trends in incidence rates of invasive lobular and ductal breast carcinoma
    Li CI JAMA 289 1421-1424 [2003]
  • The role of sarcosine metabolism in prostate cancer progression
    Khan AP Neoplasia 15 : 491 ~ 501 [2013]
  • The role of sarcosine metabolism in prostate cancer progression
    Khan AP Neoplasia 15 491-501 [2013]
  • Strategies for subtypes: dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    Goldhirsch A Ann Oncol 22 : 1736 ~ 1747 [2011]
  • Strategies for subtypes: dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    Goldhirsch A Ann Oncol 22 1736-1747 [2011]
  • Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
    De Leeuw WJ J Pathol 183 : 404 ~ 411 [1997]
  • Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
    De Leeuw WJ J Pathol 183 404-411 [1997]
  • Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression
    Jentzmik F J Urol 185 : 706 ~ 711 [2011]
  • Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression
    Jentzmik F J Urol 185 706-711 [2011]
  • Sarcosine as a potential prostate cancer biomarker and therapeutic target
    Baum CE Cancer Biol Ther 9 : 341 ~ 342 [2010]
  • Sarcosine as a potential prostate cancer biomarker and therapeutic target
    Baum CE Cancer Biol Ther 9 341-342 [2010]
  • Pathology and genetics of tumours of the breast and female genital organs
    Tavassoli FA IAPS Press [2003]
  • Pathology and genetics of tumours of the breast and female genital organs
    Tavassoli FA - [2003]
  • Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
    Elston CW Histopathology 19 : 403 ~ 410 [1991]
  • Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
    Elston CW Histopathology 19 403-410 [1991]
  • Multicentricity and bilaterality in invasive breast carcinoma
    Lesser ML Surgery 91 : 234 ~ 240 [1982]
  • Multicentricity and bilaterality in invasive breast carcinoma
    Lesser ML Surgery 91 234-240 [1982]
  • Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study
    Lamovec J J Surg Oncol 48 : 28 ~ 33 [1991]
  • Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study
    Lamovec J J Surg Oncol 48 28-33 [1991]
  • Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
    Sreekumar A Nature 457 : 910 ~ 914 [2009]
  • Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
    Sreekumar A Nature 457 910-914 [2009]
  • Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?
    Silverstein MJ Cancer 73 : 1673 ~ 1677 [1994]
  • Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?
    Silverstein MJ Cancer 73 1673-1677 [1994]
  • Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns
    Sastre-Garau X Cancer 77 : 113 ~ 120 [1996]
  • Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns
    Sastre-Garau X Cancer 77 113-120 [1996]
  • Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma
    Riva C Virchows Arch 447 : 695 ~ 700 [2005]
  • Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma
    Riva C Virchows Arch 447 695-700 [2005]
  • Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis
    Reeves GK Lancet Oncol 7 : 910 ~ 918 [2006]
  • Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis
    Reeves GK Lancet Oncol 7 910-918 [2006]
  • Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer
    Won KY Hum Pathol 41 : 107 ~ 112 [2010]
  • Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer
    Won KY Hum Pathol 41 107-112 [2010]
  • Clinical characteristics of different histologic types of breast cancer
    Li CI Br J Cancer 93 : 1046 ~ 1052 [2005]
  • Clinical characteristics of different histologic types of breast cancer
    Li CI Br J Cancer 93 1046-1052 [2005]
  • Androgen response element of the glycine N-methyltransferase gene is located in the coding region of its first exon
    Lee CM Biosci Rep 33 : e00070 ~ [2013]
  • Androgen response element of the glycine N-methyltransferase gene is located in the coding region of its first exon
    Lee CM Biosci Rep 33 e00070- [2013]
  • American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    Hammond ME J Clin Oncol 28 : 2784 ~ 2795 [2010]
  • American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    Hammond ME J Clin Oncol 28 2784-2795 [2010]
  • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    Wolff AC J Clin Oncol 25 : 118 ~ 145 [2007]
  • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    Wolff AC J Clin Oncol 25 118-145 [2007]
  • Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study
    Li CI J Natl Cancer Inst : 1422 ~ 1431 [2010]
  • Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study
    Li CI J Natl Cancer Inst 102 1422-1431 [2010]